Literature DB >> 31206467

Animal Models: Challenges and Opportunities to Determine Optimal Experimental Models of Pancreatitis and Pancreatic Cancer.

Jami L Saloman, Kathryn M Albers, Zobeida Cruz-Monserrate1, Brian M Davis, Mouad Edderkaoui2, Guido Eibl3, Ariel Y Epouhe, Jeremy Y Gedeon, Fred S Gorelick, Paul J Grippo4, Guy E Groblewski5, Sohail Z Husain6, Keane K Y Lai, Stephen J Pandol2, Aliye Uc7, Li Wen8, David C Whitcomb9.   

Abstract

At the 2018 PancreasFest meeting, experts participating in basic research met to discuss the plethora of available animal models for studying exocrine pancreatic disease. In particular, the discussion focused on the challenges currently facing the field and potential solutions. That meeting culminated in this review, which describes the advantages and limitations of both common and infrequently used models of exocrine pancreatic disease, namely, pancreatitis and exocrine pancreatic cancer. The objective is to provide a comprehensive description of the available models but also to provide investigators with guidance in the application of these models to investigate both environmental and genetic contributions to exocrine pancreatic disease. The content covers both nongenic and genetically engineered models across multiple species (large and small). Recommendations for choosing the appropriate model as well as how to conduct and present results are provided.

Entities:  

Mesh:

Year:  2019        PMID: 31206467      PMCID: PMC6581211          DOI: 10.1097/MPA.0000000000001335

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  303 in total

1.  Pancreatic cancer pain and its correlation with changes in tumor vasculature, macrophage infiltration, neuronal innervation, body weight and disease progression.

Authors:  Theodore H Lindsay; Beth M Jonas; Molly A Sevcik; Kazufumi Kubota; Kyle G Halvorson; Joseph R Ghilardi; Michael A Kuskowski; Edward B Stelow; Pinku Mukherjee; Sandra J Gendler; Gilbert Y Wong; Patrick W Mantyh
Journal:  Pain       Date:  2005-11-18       Impact factor: 6.961

2.  [Psychosomatic reflections].

Authors:  J M Oughourlian
Journal:  Ann Med Psychol (Paris)       Date:  1976-05       Impact factor: 0.380

3.  Repeated administration of a mild acute toxic dose of di-n-butyltin dichloride at intervals of 3 weeks induces severe lesions in pancreas and liver of rats.

Authors:  J Merkord; H Weber; G Kröning; G Hennighausen
Journal:  Hum Exp Toxicol       Date:  2001-08       Impact factor: 2.903

4.  Serum pancreatic polypeptide and amylase concentrations in dogs with experimentally induced acute pancreatitis.

Authors:  R J Murtaugh; R M Jacobs; R G Sherding; T M O'Dorisio
Journal:  Am J Vet Res       Date:  1985-03       Impact factor: 1.156

Review 5.  Ductal pancreatic cancer in humans and mice.

Authors:  D A Tuveson; S R Hingorani
Journal:  Cold Spring Harb Symp Quant Biol       Date:  2005

6.  An experimental model of autoimmune pancreatitis in the rat.

Authors:  Todd S Davidson; Daniel S Longnecker; William F Hickey
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.

Authors:  Bobby Yanagawa; O Brad Spiller; David G Proctor; Jonathan Choy; Honglin Luo; Huifang M Zhang; Agripina Suarez; Decheng Yang; Bruce M McManus
Journal:  J Infect Dis       Date:  2004-04-05       Impact factor: 5.226

8.  Transient receptor potential vanilloid 1 mediates hyperalgesia and is up-regulated in rats with chronic pancreatitis.

Authors:  Guang-Yin Xu; John H Winston; Mohan Shenoy; Huaizhi Yin; Swaroop Pendyala; Pankaj Jay Pasricha
Journal:  Gastroenterology       Date:  2007-06-20       Impact factor: 22.682

9.  Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway.

Authors:  Liang Han; Jiguang Ma; Wanxing Duan; Lun Zhang; Shuo Yu; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Zheng Wu; Jason H Huang; Erxi Wu; Qingyong Ma; Zhenhua Ma
Journal:  Oncotarget       Date:  2016-04-05

10.  A novel experimental model for human mixed acinar-ductal pancreatic cancer.

Authors:  Bruno Doiron; Ralph A DeFronzo
Journal:  Carcinogenesis       Date:  2018-02-09       Impact factor: 4.944

View more
  6 in total

1.  Barriers and Research Priorities for Implementing Precision Medicine.

Authors:  David C Whitcomb
Journal:  Pancreas       Date:  2019 Nov/Dec       Impact factor: 3.327

2.  Serum biomarkers for chronic pancreatitis pain patterns.

Authors:  Jami L Saloman; Gong Tang; Kimberly M Stello; Kristen E Hall; Xianling Wang; Samer AlKaade; Peter A Banks; Randall E Brand; Darwin L Conwell; Gregory A Coté; Christopher E Forsmark; Timothy B Gardner; Andres Gelrud; Michele D Lewis; Stuart Sherman; Adam Slivka; David C Whitcomb; Dhiraj Yadav
Journal:  Pancreatology       Date:  2021-09-30       Impact factor: 3.996

3.  Acute pancreatitis-induced islet dysfunction in ferrets.

Authors:  Yaling Yi; Xingshen Sun; Bo Liang; Nan He; Katherine N Gibson-Corley; Andrew W Norris; John F Engelhardt; Aliye Uc
Journal:  Pancreatology       Date:  2021-05-11       Impact factor: 3.977

4.  Heterogeneous Effects of Calorie Content and Nutritional Components Underlie Dietary Influence on Pancreatic Cancer Susceptibility.

Authors:  James Dooley; Vasiliki Lagou; Jermaine Goveia; Anna Ulrich; Katerina Rohlenova; Nathalie Heirman; Tobias Karakach; Yulia Lampi; Shawez Khan; Jun Wang; Tom Dresselaers; Uwe Himmelreich; Marc J Gunter; Inga Prokopenko; Peter Carmeliet; Adrian Liston
Journal:  Cell Rep       Date:  2020-07-14       Impact factor: 9.423

Review 5.  Pathological Changes in Pancreatic Carcinogenesis: A Review.

Authors:  Keiko Yamakawa; Juanjuan Ye; Yuko Nakano-Narusawa; Yoko Matsuda
Journal:  Cancers (Basel)       Date:  2021-02-08       Impact factor: 6.639

6.  Uncovering the Pharmacology of Xiaochaihu Decoction in the Treatment of Acute Pancreatitis Based on the Network Pharmacology.

Authors:  Lianghui Zhan; Jinbao Pu; Yijuan Hu; Pan Xu; Weiqing Liang; Chunlian Ji
Journal:  Biomed Res Int       Date:  2021-03-20       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.